SCHEMBL1825970

SCHEMBL1825970

CC(OCc1ccccc1)c1ccccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
ACHE P22303 1/20 0.39
MAPT P10636 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
METAP2 P50579 1/20 0.39
METAP1 P53582 1/20 0.39
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
HTR6 P50406 1/20 0.36
HSD11B1 P28845 1/20 0.36
HSD17B3 P37058 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 3/20 0.36
GAA P10253 2/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823668 0.92 LMNA (0.44) ALDH1A1ACHEMAPTL3MBTL1KMT2A
SCHEMBL1825221 0.86 CA1 (0.41) CA1CA2ACHEMAPTL3MBTL1
SCHEMBL1823526 0.82 MAPT (0.41) ALDH1A1CA1CA2ACHEMAPT
SCHEMBL1822252 0.81 ALDH1A1 (0.48) ALDH1A1CA1CA2ACHEMAPT
SCHEMBL3571449 0.81 ALDH1A1 (0.44) ALDH1A1CA1CA2MAPTL3MBTL1
SCHEMBL1827103 0.81 ALDH1A1 (0.49) ALDH1A1CA1CA2ACHEMAPT
SCHEMBL2838943 0.80 CA1 (0.47) ALDH1A1CA1CA2ACHEMAPT
SCHEMBL1823275 0.80 CA1 (0.45) ALDH1A1CA1CA2ACHEMAPT
SCHEMBL1827753 0.79 MAPT (0.41) ALDH1A1CA1CA2ACHEMAPT
SCHEMBL5653055 0.79 CA1 (0.46) ALDH1A1CA1CA2ACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ALDH1A1 1099/4885CA1 1603/4885CA2 730/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ALDH1A1 1440/4885CA1 1728/4885CA2 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.